News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
M1 Kliniken AG's Supervisory Board approves 2023 financial statements with EUR 0.50 per share dividend proposal. Anticipates sales and earnings growth in 2024 -
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH releases a research update on M1 Kliniken AG, reiterating a BUY rating and EUR 18.00 price target, based on strong 2023 Beauty segment results and continued expansion. Contact details provided -
-
-
-